We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




New Blood Test Device Modeled on Leeches to Help Diagnose Malaria

By LabMedica International staff writers
Posted on 06 May 2024
Print article
Image: The new method is quick and easy, and can also be used by non-medical personnel. (Photo courtesy of Zoratto et al. Advanced Science 2024, edited)
Image: The new method is quick and easy, and can also be used by non-medical personnel. (Photo courtesy of Zoratto et al. Advanced Science 2024, edited)

Many individuals have a fear of needles, making the experience of having blood drawn from their arm particularly distressing. An alternative method involves taking blood from the fingertip or earlobe, but this often yields insufficient blood for many tests and can result in inaccurate laboratory values that vary between measurements. Now, researchers have developed an innovative device that uses microneedles and a suction cup instead of a large needle, which could be especially beneficial for those with needle phobia. This device can collect more blood than the traditional finger prick, enhancing the reliability of diagnostic measurements. Additionally, its low production cost makes it feasible for use in developing countries.

The new device for taking blood samples developed by researchers at ETH Zurich (Zurich, Switzerland) operates on a principle similar to that of a leech and is less invasive than traditional arm blood draws. It is user-friendly and can be operated by individuals without medical training. Although it does not gather as much blood as a conventional needle, it significantly surpasses the volume collected from a finger prick. The concept for this device emerged while the ETH researchers were developing a suction cup intended to administer medication through the mucous membranes inside the mouth, during which they studied how leeches attach to their hosts using a sucker and then draw blood.

The device mimics how leeches work: after attaching, they penetrate the skin with their teeth and create negative pressure to draw blood. Similarly, the new device features a suction cup about two and a half centimeters in diameter that adheres to the patient's upper arm or back. It houses a dozen microneedles that pierce the skin when pressed against it. Within minutes, the negative pressure collects enough blood for diagnostic testing. This cost-effective device could be especially useful in regions like sub-Saharan Africa, where it could significantly impact the fight against diseases such as malaria.

An additional safety feature of this device is that the microneedles are enclosed within the suction cup, reducing the risk of injury both during use and after disposal, unlike conventional needles. Currently, the suction cup is made of silicone, and the microneedles are steel, but the team is developing a version using fully biodegradable materials. While this device has been tested on pigs and extensive manufacturing details have been prepared, further optimization of the materials and safe use testing in humans are needed. The researchers are hopeful that their innovative device will soon be aiding the health of children and all who fear needles.

Related Links:
ETH Zurich 

Gold Member
Chagas Disease Test
CHAGAS Cassette
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Creatine Kinase-MB Assay
CK-MB Test
New
Ultrasonic Cleaner
UC 300 Series

Print article

Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.